Split History
ETFs Holding ZGNX »    ZGNX Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Zogenix is a global pharmaceutical company that is developing and commercializing therapies to improve the lives of patients and their families living with rare diseases. Co. is primarily focused on developing and commercializing two therapeutic product candidates: Fintepla, a low-dose fenfluramine, for two pediatric epilepsy disorders and MT1621 for a mitochondrial depletion disorder. Co. owns and controls worldwide development and commercialization rights to Fintepla, its primary product candidate. Fintepla is also under late-stage development for the treatment of seizures associated with Lennox-Gastaut syndrome, another form of childhood-onset epilepsy. According to our ZGNX split history records, Zogenix has had 1 split.
ZGNX split history picture
Zogenix (ZGNX) has 1 split in our ZGNX split history database. The split for ZGNX took place on July 01, 2015. This was a 1 for 8 reverse split, meaning for each 8 shares of ZGNX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 125 share position following the split.

When a company such as Zogenix conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the ZGNX split history from start to finish, an original position size of 1000 shares would have turned into 125 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Zogenix shares, starting with a $10,000 purchase of ZGNX, presented on a split-history-adjusted basis factoring in the complete ZGNX split history. ZGNX split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/24/2011
End date: 06/23/2021
Start price/share: $32.00
End price/share: $17.13
Dividends collected/share: $0.00
Total return: -46.47%
Average Annual Total Return: -6.05%
Starting investment: $10,000.00
Ending investment: $5,355.74
Years: 10.01
Date Ratio
07/01/20151 for 8
ZGNX is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ZLCS Split History
ZSAN Split History
A Split History
AAC Split History
ABC Split History
ABIO Split History
ABMD Split History
ABT Split History
ABV Split History
ACER Split History

Also explore: ZGNX shares outstanding history

Trisura Group Ltd. (TSU.CA)
BetaPro NASDAQ-100 2x Daily Bull ETF (HQU)
BetaPro S&P 500 2x Daily Bull ETF (HSU)
BetaPro S&P/TSX Capped Energy 2x Daily Bull ETF (HEU)
BetaPro S&P/TSX Capped Financials 2x Daily Bull ETF (HFU)
BetaPro S&P/TSX 60 2x Daily Bull ETF (HXU)
BetaPro Crude Oil Leveraged Daily Bull ETF (HOU)
Horizons Big Data & Hardware Index ETF (HBGD.U)
Horizons Big Data & Hardware Index ETF (HBGD)
Horizons NASDAQ-100 Index ETF (HXQ.U)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

ZGNX Insider Buying

ZGNX Split History | www.SplitHistory.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.